Couvreur P - Search Results

1

Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma.

Toub N, Bertrand JR, Tamaddon A, Elhamess H, Hillaireau H, Maksimenko A, Maccario J, Malvy C, Fattal E, Couvreur P. Toub N, et al. Among authors: couvreur p. Pharm Res. 2006 May;23(5):892-900. doi: 10.1007/s11095-006-9901-9. Epub 2006 May 2. Pharm Res. 2006. PMID: 16715379

2

Oligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies.

Maksimenko A, Malvy C, Lambert G, Bertrand JR, Fattal E, Maccario J, Couvreur P. Maksimenko A, et al. Among authors: couvreur p. Pharm Res. 2003 Oct;20(10):1565-7. doi: 10.1023/a:1026122914852. Pharm Res. 2003. PMID: 14620508

3

Antisense oligonucleotide nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing's sarcoma model.

Toub N, Bertrand JR, Malvy C, Fattal E, Couvreur P. Toub N, et al. Among authors: couvreur p. Oligonucleotides. 2006 Summer;16(2):158-68. doi: 10.1089/oli.2006.16.158. Oligonucleotides. 2006. PMID: 16764539

4

New core-shell nanoparticules for the intravenous delivery of siRNA to experimental thyroid papillary carcinoma.

de Martimprey H, Bertrand JR, Malvy C, Couvreur P, Vauthier C. de Martimprey H, et al. Among authors: couvreur p. Pharm Res. 2010 Mar;27(3):498-509. doi: 10.1007/s11095-009-0043-8. Epub 2010 Jan 20. Pharm Res. 2010. PMID: 20087631

5

Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides.

Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P. Lambert G, et al. Among authors: couvreur p. Pharm Res. 2000 Jun;17(6):707-14. doi: 10.1023/a:1007582332491. Pharm Res. 2000. PMID: 10955845

6

EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice.

Lambert G, Bertrand JR, Fattal E, Subra F, Pinto-Alphandary H, Malvy C, Auclair C, Couvreur P. Lambert G, et al. Among authors: couvreur p. Biochem Biophys Res Commun. 2000 Dec 20;279(2):401-6. doi: 10.1006/bbrc.2000.3963. Biochem Biophys Res Commun. 2000. PMID: 11118299

7

Cellular fate of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate).

Toub N, Angiari C, Eboué D, Fattal E, Tenu JP, Le Doan T, Couvreur P. Toub N, et al. Among authors: couvreur p. J Control Release. 2005 Aug 18;106(1-2):209-13. doi: 10.1016/j.jconrel.2005.03.029. J Control Release. 2005. PMID: 15951045

8

In vivo potentialities of EWS-Fli-1 targeted antisense oligonucleotides-nanospheres complexes.

Maksimenko A, Polard V, Villemeur M, Elhamess H, Couvreur P, Bertrand JR, Aboubakar M, Gottikh M, Malvy C. Maksimenko A, et al. Among authors: couvreur p. Ann N Y Acad Sci. 2005 Nov;1058:52-61. doi: 10.1196/annals.1359.010. Ann N Y Acad Sci. 2005. PMID: 16394125

9

siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma.

de Martimprey H, Bertrand JR, Fusco A, Santoro M, Couvreur P, Vauthier C, Malvy C. de Martimprey H, et al. Among authors: couvreur p. Nucleic Acids Res. 2008 Jan;36(1):e2. doi: 10.1093/nar/gkm1094. Epub 2007 Dec 13. Nucleic Acids Res. 2008. PMID: 18079153 Free PMC article.

10

Physicochemical characteristics and preliminary in vivo biological evaluation of nanocapsules loaded with siRNA targeting estrogen receptor alpha.

Bouclier C, Moine L, Hillaireau H, Marsaud V, Connault E, Opolon P, Couvreur P, Fattal E, Renoir JM. Bouclier C, et al. Among authors: couvreur p. Biomacromolecules. 2008 Oct;9(10):2881-90. doi: 10.1021/bm800664c. Epub 2008 Sep 13. Biomacromolecules. 2008. PMID: 18788777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters